HCFA Officials Looking To Expand Interagency Collaboration To NHLBI
This article was originally published in The Gray Sheet
Executive Summary
HCFA, FDA and National Heart, Lung and Blood Institute officials will discuss the week of March 19 plans for a multi-agency committee to serve as a sounding board for manufacturers in the process of developing new medical technologies.
You may also be interested in...
CMS Coverage, FDA Review Process Overlap Studied By HHS Secretary Panel
The HHS Secretary's Advisory Committee on Regulatory Reform will consider proposals to coordinate CMS' coverage analysis process with FDA's evaluation of new technologies to prevent duplicative requirements
CMS Coverage, FDA Review Process Overlap Studied By HHS Secretary Panel
The HHS Secretary's Advisory Committee on Regulatory Reform will consider proposals to coordinate CMS' coverage analysis process with FDA's evaluation of new technologies to prevent duplicative requirements
Fischer Angling For Swift Mammography Device Review Following IoM Report
Fischer Imaging's hopes for a relatively quick turnaround of its March 12 PMA submission for the SenoScan digital mammography system could be boosted by the possibility that the device will not have to go before an FDA advisory panel, the Denver-based firm said.